Parkinson’s and Protein Phosphorylation
Parkinson’s disease is characterized by the accumulation of a protein known as alpha-synuclein in the brain. If too much of it is produced or if it’s not eliminated properly, it…
Read article
Research news
Can Skin Cream Help?
Science Daily reports in its 15 August edition that the active ingredient in an over-the-counter skin cream might slow or stop the effects of Parkinson’s disease on brain cells. Scientists…
Michael J. Fox Foundation awards grant for Exenatide research
Following encouraging results recently published in the Journal of Clinical Investigation describing the progress of a cohort of patients treated with Exenatide for their Parkinson’s disease (PD), The Michael J.…
Stem Cell Programming Advance
Scientists based at the University of Edinburgh’s MRC Centre for Regenerative Medicine (CRM) and Anne Rowling Clinic have taken a vital step forward in understanding how cells from skin tissue…
Exenatide may be disease-modifying for PD
Exenatide is a type 2 diabetes treatment that has been shown to have neuroprotective/neurorestorative properties in preclinical models of neurodegeneration. A new study by Aviles-Olmos et al published in the…
Brain-Imaging Technique Can Help Diagnose Movement Disorders
A new University of Florida study suggests a promising brain-imaging technique has the potential to improve diagnoses for the millions of people with movement disorders such as Parkinson’s disease. Science…